Effects of Sodium-glucose Co-transporter-2( SGLT-2 ) Inhibition on Sympathetic Nervous System Activity in Humans

Clinical trial NCT03912909 · UNKNOWN

Trial details

NCT number: NCT03912909
Sponsor: Royal Perth Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Metabolic Syndrome Type 2 Diabetes Mellitus Obesity

Start date: 2018-08-01
Primary completion: 2024-03-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.